vs
Side-by-side financial comparison of Arhaus, Inc. (ARHS) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
Arhaus, Inc. is the larger business by last-quarter revenue ($364.8M vs $196.0M, roughly 1.9× Axsome Therapeutics, Inc.). Arhaus, Inc. runs the higher net margin — 4.1% vs -14.6%, a 18.7% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 5.1%). Arhaus, Inc. produced more free cash flow last quarter ($-8.8M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 11.2%).
Arhaus, Inc.ARHSEarnings & Financial Report
Arhaus, Inc. is an upscale American home furnishings company headquartered in Boston Heights, Ohio. Founded in 1986 with a focus on sustainability and artisanship in product quality, Arhaus provides a diversified assortment of specialty goods and services addressing omnichannel direct-to-consumer and business-to-business residential and commercial operations.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
ARHS vs AXSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $364.8M | $196.0M |
| Net Profit | $15.1M | $-28.6M |
| Gross Margin | 38.1% | — |
| Operating Margin | 5.6% | -13.8% |
| Net Margin | 4.1% | -14.6% |
| Revenue YoY | 5.1% | 65.0% |
| Net Profit YoY | -29.1% | 61.9% |
| EPS (diluted) | $0.11 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $364.8M | $196.0M | ||
| Q3 25 | $344.6M | $171.0M | ||
| Q2 25 | $358.4M | $150.0M | ||
| Q1 25 | $311.4M | $121.5M | ||
| Q4 24 | $347.0M | $118.8M | ||
| Q3 24 | $319.1M | $104.8M | ||
| Q2 24 | $309.8M | $87.2M | ||
| Q1 24 | $295.2M | $75.0M |
| Q4 25 | $15.1M | $-28.6M | ||
| Q3 25 | $12.2M | $-47.2M | ||
| Q2 25 | $35.1M | $-48.0M | ||
| Q1 25 | $4.9M | $-59.4M | ||
| Q4 24 | $21.3M | $-74.9M | ||
| Q3 24 | $9.9M | $-64.6M | ||
| Q2 24 | $22.2M | $-79.3M | ||
| Q1 24 | $15.1M | $-68.4M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 41.4% | — | ||
| Q1 25 | 37.1% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 38.6% | — | ||
| Q2 24 | 40.1% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 5.6% | -13.8% | ||
| Q3 25 | 4.8% | -27.0% | ||
| Q2 25 | 13.0% | -24.5% | ||
| Q1 25 | 1.7% | -46.9% | ||
| Q4 24 | 8.2% | -61.1% | ||
| Q3 24 | 3.3% | -59.8% | ||
| Q2 24 | 9.5% | -89.5% | ||
| Q1 24 | 6.2% | -89.7% |
| Q4 25 | 4.1% | -14.6% | ||
| Q3 25 | 3.5% | -27.6% | ||
| Q2 25 | 9.8% | -32.0% | ||
| Q1 25 | 1.6% | -48.9% | ||
| Q4 24 | 6.1% | -63.1% | ||
| Q3 24 | 3.1% | -61.7% | ||
| Q2 24 | 7.2% | -91.0% | ||
| Q1 24 | 5.1% | -91.1% |
| Q4 25 | $0.11 | $-0.55 | ||
| Q3 25 | $0.09 | $-0.94 | ||
| Q2 25 | $0.25 | $-0.97 | ||
| Q1 25 | $0.03 | $-1.22 | ||
| Q4 24 | $0.15 | $-1.54 | ||
| Q3 24 | $0.07 | $-1.34 | ||
| Q2 24 | $0.16 | $-1.67 | ||
| Q1 24 | $0.11 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $253.4M | $322.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $418.2M | $88.3M |
| Total Assets | $1.4B | $689.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $253.4M | $322.9M | ||
| Q3 25 | $262.2M | $325.3M | ||
| Q2 25 | $234.8M | $303.0M | ||
| Q1 25 | $214.4M | $300.9M | ||
| Q4 24 | $197.5M | $315.4M | ||
| Q3 24 | $177.7M | $327.3M | ||
| Q2 24 | $174.2M | $315.7M | ||
| Q1 24 | $233.2M | $331.4M |
| Q4 25 | $418.2M | $88.3M | ||
| Q3 25 | $400.4M | $73.7M | ||
| Q2 25 | $385.6M | $73.1M | ||
| Q1 25 | $348.8M | $53.2M | ||
| Q4 24 | $343.7M | $57.0M | ||
| Q3 24 | $320.6M | $92.9M | ||
| Q2 24 | $309.3M | $102.9M | ||
| Q1 24 | $285.6M | $144.0M |
| Q4 25 | $1.4B | $689.8M | ||
| Q3 25 | $1.4B | $669.3M | ||
| Q2 25 | $1.3B | $639.8M | ||
| Q1 25 | $1.3B | $596.7M | ||
| Q4 24 | $1.2B | $568.5M | ||
| Q3 24 | $1.2B | $561.5M | ||
| Q2 24 | $1.2B | $548.2M | ||
| Q1 24 | $1.2B | $545.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.3M | $-18.7M |
| Free Cash FlowOCF − Capex | $-8.8M | $-18.7M |
| FCF MarginFCF / Revenue | -2.4% | -9.6% |
| Capex IntensityCapex / Revenue | 5.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.0M | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.3M | $-18.7M | ||
| Q3 25 | $46.1M | $1.0M | ||
| Q2 25 | $34.9M | $-32.4M | ||
| Q1 25 | $46.5M | $-43.4M | ||
| Q4 24 | $31.7M | $-26.2M | ||
| Q3 24 | $31.1M | $-18.6M | ||
| Q2 24 | $47.5M | $-30.1M | ||
| Q1 24 | $36.8M | $-53.5M |
| Q4 25 | $-8.8M | $-18.7M | ||
| Q3 25 | $28.0M | $988.0K | ||
| Q2 25 | $20.9M | $-32.4M | ||
| Q1 25 | $18.9M | $-43.7M | ||
| Q4 24 | $13.0M | $-26.2M | ||
| Q3 24 | $4.6M | $-18.7M | ||
| Q2 24 | $11.3M | $-30.2M | ||
| Q1 24 | $10.9M | $-53.6M |
| Q4 25 | -2.4% | -9.6% | ||
| Q3 25 | 8.1% | 0.6% | ||
| Q2 25 | 5.8% | -21.6% | ||
| Q1 25 | 6.1% | -36.0% | ||
| Q4 24 | 3.7% | -22.1% | ||
| Q3 24 | 1.4% | -17.9% | ||
| Q2 24 | 3.6% | -34.6% | ||
| Q1 24 | 3.7% | -71.4% |
| Q4 25 | 5.0% | 0.0% | ||
| Q3 25 | 5.3% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 8.9% | 0.3% | ||
| Q4 24 | 5.4% | 0.0% | ||
| Q3 24 | 8.3% | 0.1% | ||
| Q2 24 | 11.7% | 0.1% | ||
| Q1 24 | 8.8% | 0.1% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 3.77× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 9.53× | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 3.14× | — | ||
| Q2 24 | 2.14× | — | ||
| Q1 24 | 2.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARHS
| Sales Channel Retail | $305.7M | 84% |
| Sales Channel E Commerce | $59.2M | 16% |
AXSM
Segment breakdown not available.
